Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIT vs VI in Relapsed or Refractory Rhabdomyosarcoma
NCT01355445Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Jan 2012
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in rhabdomyosarcoma (RMS), sponsored by Centre Oscar Lambret. Started Jan 2012; status: completed.
02
Drugs
temozolomide
03
Conditions
rhabdomyosarcoma (RMS)
Beyond the preview
Go deeper on NCT01355445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01355445.